News
Viking Therapeutics Unusual Options Activity
26 Apr 24
Options, Markets
HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $90 Price Target
25 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO
24 Apr 24
Biotech, Earnings, News, Health Care, After-Hours Center, Movers
Viking Therapeutics Q1 EPS $(0.26) Beats $(0.28) Estimate
24 Apr 24
Earnings, Earnings Beats, News
Looking At Viking Therapeutics's Recent Unusual Options Activity
22 Apr 24
Options, Markets
Market Whales and Their Recent Bets on VKTX Options
18 Apr 24
Options, Markets
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
15 Apr 24
News, Trading Ideas
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
9 Apr 24
Options, Markets
10 Health Care Stocks Whale Activity In Today's Session
4 Apr 24
Options
10 Health Care Stocks Whale Activity In Today's Session
3 Apr 24
Options
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
2 Apr 24
News, Trading Ideas
Looking Into Viking Therapeutics's Recent Short Interest
1 Apr 24
Short Sellers, Short Ideas, Trading Ideas
Oppenheimer Maintains Outperform on Viking Therapeutics, Raises Price Target to $138
27 Mar 24
News, Price Target, Analyst Ratings
Oppenheimer Maintains Outperform on Viking Therapeutics, Raises Price Target to $138
26 Mar 24
News, Price Target, Analyst Ratings
Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
26 Mar 24
Top Stories
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
26 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
BTIG Maintains Buy on Viking Therapeutics, Raises Price Target to $125
26 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $90 Price Target
26 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Viking Therapeutics' Investigational Oral Obesity Drug Shows Reduced Weight In Small Study
26 Mar 24
Biotech, News, Health Care, Movers, General
Market-Moving News for March 26th
26 Mar 24
Movers, Trading Ideas
Press releases
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
24 Apr 24
Earnings, Press Releases
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
18 Apr 24
News, Press Releases
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
17 Apr 24
Small Cap, Press Releases
Thinking about trading options or stock in Micron Technology, Apple, Viking Therapeutics, Marvell Technology, or Vertiv Holdings?
1 Apr 24
Opinion, Press Releases
Thinking about trading options or stock in NVIDIA, Vale, Viking Therapeutics, GigaCloud Technology, or Crowdstrike Holdings?
27 Mar 24
Opinion, Press Releases
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
26 Mar 24
Press Releases
Thinking about trading options or stock in Advanced Micro Devices, Amazon.com, Intel, GSK, or Viking Therapeutics?
21 Mar 24
Opinion, Press Releases
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
4 Mar 24
Offerings, Press Releases
Thinking about buying stock in Volcon, Abeona Therapeutics, Agenus, Viking Therapeutics, or Compugen?
29 Feb 24
Opinion, Press Releases
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
28 Feb 24
Offerings, Small Cap, Press Releases
Viking Therapeutics Announces Proposed Public Offering of Common Stock
27 Feb 24
Offerings, Small Cap, Press Releases
Thinking about trading options or stock in Alphabet Inc, Autozone, Zoom Video Communications, TransMedics Group, or Viking Therapeutics?
27 Feb 24
Opinion, Press Releases
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
27 Feb 24
Small Cap, Press Releases
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
Press Releases
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
7 Feb 24
Earnings, Press Releases
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2023 on February 7, 2024
31 Jan 24
Small Cap, Press Releases